CN Patent

CN104394691A — 用5-氨基水杨酸治疗过敏性肠道综合症的组合物和方法

Assigned to Dr Falk Pharma GmbH · Expires 2015-03-04 · 11y expired

What this patent protects

实施方式涉及用5-氨基水杨酸治疗肠胃病症的组合物及相关方法。在一些实施方式中，所治疗的肠胃病症是过敏性肠道综合症(IBS)。在一些实施方式中，所治疗的肠胃病症是腹泻型过敏性肠道综合症(d-IBS)。

USPTO Abstract

实施方式涉及用5-氨基水杨酸治疗肠胃病症的组合物及相关方法。在一些实施方式中，所治疗的肠胃病症是过敏性肠道综合症(IBS)。在一些实施方式中，所治疗的肠胃病症是腹泻型过敏性肠道综合症(d-IBS)。

Drugs covered by this patent

Patent Metadata

Patent number
CN104394691A
Jurisdiction
CN
Classification
—
Expires
2015-03-04
Drug substance claim
No
Drug product claim
No
Assignee
Dr Falk Pharma GmbH
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.